Prophylactic Amnioinfusion for Prevention of Postpartum Hemorrhage

The purpose of this study is to decrease the likelihood of composite postpartum hemorrhage (PPH) morbidity, which consists of i) Estimated or quantified blood loss of 1,500 mL or more, ii) transfusion of any blood products or iii) hysterectomy

NCT Number	NCT06691945
Lead Sponsor	The University of Texas Health Science Center, Houston
Conditions	Postpartum Hemorrhage
Enrollment	700 participants
Start Date	2024-11-11
Primary Completion	2026-11-11 (estimated)
Study Completion	2027-05-01 (estimated)
Updated on ClinicalTrials.gov	2024-11-18